慢性肺全移植功能障碍的手术治疗
概括
慢性肺异位移植功能障碍 (CLAD) 显著影响肺移植存活率. 这次审查涵盖了CLAD.
科学领域:
- 肺病学和移植医学 肺病学和移植医学
- 免疫学 免疫学 免疫学
- 手术创新 在外科创新.
背景情况:
- 肺移植是末期肺病的重要治疗方法.
- 慢性肺异位移植功能障碍 (CLAD) 是长期移植存活的主要威胁.
- 了解CLAD的病理和临床特征对于患者管理至关重要.
结论:
- 有效管理CLAD需要一个多方面的方法,整合手术和非手术策略.
- 进一步的研究是必要的,以改善肺移植接受者面临CLAD.的长期结果.
- 优化患者护理包括通过既有和新的治疗途径来解决CLAD的复杂性.
相关概念视频
Acute Respiratory Failure-V
140
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
140
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
Pneumothorax-II
150
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
150
Cystic Fibrosis: Management
164
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
164


